The largest US drugstore operator Walgreens Boots Alliance has made a takeover approach to drug distributor AmerisourceBergen the Wall Street Journal reported on Monday, outlining a deal that would accelerate healthcare sector consolidation.
Walgreens is valued at $67.82 billion and AmerisourceBergen has a market capitalization of US$19.65 billion, according to WSJ.
Healthcare payers and pharmacies are responding to a shifting landscape, including changes in the US Affordable Care Act, rising drug prices and the threat of competition from online retailers such as Amazon.com.
A new deal by Walgreens would follow the US$69 billion acquisition of health insurer Aetna Inc by drugstore rival CVS Health Corp and would also reflect a move toward vertical consolidation, where members of a supply chain combine.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI